
Figure 2. Immunohistochemistry validation of DBI using Anti-ACBP DBI Antibody (A01267-2). Immunohistochemical analysis of paraffin-embedded human lung cancer. Antibody was diluted at 1:100 (4°C
Anti-ACBP DBI Antibody
A01267-2
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetDBI
Overview
- SupplierBoster Bio
- Product NameAnti-ACBP DBI Antibody
- Delivery Days Customer9
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- Gene ID1622
- Target nameDBI
- Target descriptiondiazepam binding inhibitor, acyl-CoA binding protein
- Target synonymsACBD1, ACBP, CCK-RP, EP, acyl-CoA-binding protein, GABA receptor modulator, acyl coenzyme A binding protein, acyl-Coenzyme A binding domain containing 1, cholecystokinin-releasing peptide, trypsin-sensitive, diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein), diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A binding protein), diazepam-binding inhibitor, endozepine, epididymis secretory sperm binding protein
- HostRabbit
- IsotypeIgG
- Protein IDP07108
- Protein NameAcyl-CoA-binding protein
- Scientific DescriptionBoster Bio Anti-ACBP DBI Antibody catalog # A01267-2. Tested in WB, IHC, IF, ELISA applications. This antibody reacts with Human, Mouse, Rat.
- ReactivityHuman, Mouse, Rat
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203








